CIK 0001714899 · Large accelerated filer
Denali Therapeutics Inc.
Sign in to watch- Ticker
- DNLI
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 463872213
- Phone
- (650) 866-8547
- Business address
- 161 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $363,678
- in 3 filings, $327K under 10b5-1 plans
Net −$363,678. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 8 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-06-01 | Cook Jennifer E. Director | Grant or award | +4,216 | 15,529 | ||
| 2023-06-01 | Cook Jennifer E. Director | Grant or award · Stock Option (right to buy) | +12,649 | 12,649 | ||
| 2023-06-01 | Schenkein David P Director | Grant or award | +4,216 | 15,529 | ||
| 2023-06-01 | Schenkein David P Director | Grant or award · Stock Option (right to buy) | +12,649 | 12,649 | ||
| 2023-06-01 | FLATLEY JAY T Director | Grant or award | +4,216 | 340,529 | ||
| 2023-06-01 | FLATLEY JAY T Director | Grant or award · Stock Option (right to buy) | +12,649 | 12,649 | ||
| 2023-06-01 | Harris Erik Director | Grant or award | +4,216 | 11,085 | ||
| 2023-06-01 | Harris Erik Director | Grant or award · Stock Option (right to buy) | +12,649 | 12,649 | ||
| 2023-06-01 | Cole Douglas G. Director | Grant or award | +4,216 | 26,564 | ||
| 2023-06-01 | Cole Douglas G. Director | Grant or award · Stock Option (right to buy) | +12,649 | 12,649 | ||
| 2023-06-01 | SATO VICKI L Director | Grant or award | +4,216 | 136,369 | ||
| 2023-06-01 | SATO VICKI L Director | Grant or award · Stock Option (right to buy) | +12,649 | 12,649 | ||
| 2023-05-15 | Schuth Alexander O. COFO and Secretary | Option exercise | +10,000 | $5.28 | $53K | 538,691 |
| 2023-05-15 | Schuth Alexander O. COFO and Secretary | Sale | −9,200 | $28.55 | $263K | 529,491 |
| 2023-05-15 | Schuth Alexander O. COFO and Secretary | Sale | −800 | $29.23 | $23K | 528,691 |
| 2023-05-15 | Schuth Alexander O. COFO and Secretary | Option exercise · Stock Option (right to buy) | −10,000 | 78,937 | ||
| 2023-04-21 | Watts Ryan J. President and CEO | Option exercise | +24,800 | $0.68 | $17K | 2,264,713 |
| 2023-04-21 | Watts Ryan J. President and CEO | Sale | −24,800 | $25.15 | $624K | 2,239,913 |
| 2023-04-21 | Watts Ryan J. President and CEO | Option exercise · Stock Option (right to buy) | −24,800 | 1,170,617 | ||
| 2023-04-20 | Watts Ryan J. President and CEO | Option exercise | +200 | $0.68 | $136 | 2,240,113 |
Page 11 of 53 · 1,043 trades